SEC Company Response from Somaxon Pharmaceuticals, Inc. (CIK 0001339455) — Dec 14, 2005
Somaxon Pharmaceuticals, Inc. (CIK 0001339455)
Date: Dec. 14, 2005 · CIK: 0001339455 · Accession: 0000936392-05-000440
AI Filing Summary & Sentiment
File numbers found in text: 333-128871
Letter
File Number 333-128871 Jeffrey Riedler, Assistant Director United States Securities and Exchange Commission Washington, D.C. 20549
Re:
Dear Mr. Riedler:
This will confirm on behalf of the underwriters for the initial public offering by Somaxon Pharmaceuticals, Inc., of 5,000,000 shares of its common stock, par value $.0001 per share, that as sole bookrunning manager Morgan Stanley & Co. Incorporated is responsible for sending out all confirmations, is able to electronically deliver copies of the issuer free writing prospectus dated the date hereof and Morgan Stanley & Co. Incorporated has agreed to orally confirm delivery of copies of such free writing prospectus (or to orally provide notice of the content thereof) to each investor prior to confirming the sale to such investor of any shares of common stock.
Very truly yours,
/s/ Bruce K. Dallas
Show Raw Text
CORRESP
1
filename1.htm
corresp
DAVIS POLK & WARDWELL
1600 El Camino Real
Menlo Park, California 94025
650 752 2022
dallas@dpw.com
December 14, 2005
Re:
Somaxon Pharmaceuticals, Inc.
Registration Statement on Form S-1
File Number 333-128871
Jeffrey Riedler, Assistant Director
United States Securities and Exchange Commission
Washington, D.C. 20549
Dear Mr. Riedler:
This will confirm on behalf of the underwriters for the initial public offering by Somaxon
Pharmaceuticals, Inc., of 5,000,000 shares of its common stock, par value $.0001 per share, that as
sole bookrunning manager Morgan Stanley & Co. Incorporated is responsible for sending out all
confirmations, is able to electronically deliver copies of the issuer free writing prospectus dated
the date hereof and Morgan Stanley & Co. Incorporated has agreed
to orally confirm delivery of copies of such free writing prospectus (or
to orally provide notice of the content thereof) to each investor
prior to confirming the sale to such investor of any shares of common
stock.
Very truly yours,
/s/ Bruce K. Dallas
Bruce K. Dallas
cc:
Bryan Andrzejewski, Morgan Stanley & Co. Incorporated
Ken Cohen, Somaxon Pharmaceuticals, Inc.
Cheston Larson, Latham & Watkins LLP
Electronic Filing